Genmab A (GMAB) Non-Current Receivables (2023 - 2025)

Genmab A's Non-Current Receivables history spans 3 years, with the latest figure at $22.0 million for Q4 2025.

  • For Q4 2025, Non-Current Receivables rose 214.29% year-over-year to $22.0 million; the TTM value through Dec 2025 reached $22.0 million, up 214.29%, while the annual FY2025 figure was $22.0 million, 214.29% up from the prior year.
  • Non-Current Receivables reached $22.0 million in Q4 2025 per GMAB's latest filing, up from $7.0 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $22.0 million in Q4 2025 to a low of $7.0 million in Q4 2024.
  • Average Non-Current Receivables over 3 years is $13.0 million, with a median of $10.0 million recorded in 2023.
  • Peak YoY movement for Non-Current Receivables: crashed 30.0% in 2024, then skyrocketed 214.29% in 2025.
  • A 3-year view of Non-Current Receivables shows it stood at $10.0 million in 2023, then decreased by 30.0% to $7.0 million in 2024, then surged by 214.29% to $22.0 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Non-Current Receivables are $22.0 million (Q4 2025), $7.0 million (Q4 2024), and $10.0 million (Q4 2023).